Abstract
Previously, we mapped the antibody (Ab) and T-cell recognition regions on the HC domain (residues 855–1296) of the 848-residue heavy (H) chain of botulinum neurotoxin A (BoNT/A). We have mapped here the HN-domain (residues 449–859) regions that bind protective anti-BoNT/A Abs raised in four different species. We synthesized, purified, and characterized 29 19-residue peptides that spanned the entire HN and overlapped consecutively by 5 residues, and also region L218–231 around the L-chain's substrate-binding site. Human, horse, mouse, and chicken anti-BoNT/A Abs did not bind to the L-peptide but recognized similar HN regions within peptides 519–537/533–551/547–565/561–579 (with slight left- or right-shifts), 743–761, 785–803, and 813–831/827–845 overlap. Recognition of other peptides that bound lower Ab levels showed similarities and also some differences. Peptide 463–481, strongly immunodominant with horse antisera, did not bind human, mouse, and chicken Abs. However, peptide 449–467 bound Abs in these three antisera, and the region may have shifted to the right (peptide 463–481) with horse Abs. The overlap 659–677/673–691 reacted strongly with human Abs whereas with mouse and chicken antisera, only peptide 673–691 showed low reactivity. Horse antisera had no detectable Ab binding to region(s) 659–691. The Ab-recognition regions on the H chain occupy surface locations in BoNT/A three-dimensional structure, but the great part of the surface is not immunogenic. Regions recognized by the protective antisera of the four different species are prime candidates for inclusion in synthetic vaccine designs.
Similar content being viewed by others
References
Aguilera, J., Ahnert-Hilger, G., Bigalke, H., DasGupta, B. R., Dolly, O., Habermann, E., et al. (1992). FEMS Microbiol. Lett. 90: 99–100.
Ahnert-Hilger, G., and Bigalke, H. (1995). Prog. Neurobiol. 46: 83–96.
Amersdorfer, P., Wong, C., Chen, S., Smith, T., Deshpande, S., Sheridan, R., Finnern, R., and Marks, J. D. (1997). Infect. Immun. 65: 3743–3752.
Atassi, M. Z. (1975). Immunochemistry 12: 423–438.
Atassi, M. Z. (1984). Eur. J. Biochem. 145: 1–20.
Atassi, M. Z., and Oshima, M. (1999). Critical Revs. Immunol. 19: 219–260.
Atassi, M. Z., and Smith, J. A. (1978). Immunochemistry 15: 609–610.
Atassi, M. Z., Yoshioka, M., Bean, M., and Bixler, G. S., Jr. (1987). Biochem. J. 246: 307–312.
Atassi, M. Z., Manshouri, T., and Sakata, S. (1991). Proc. Natl. Acad. Sci. U. S. A. 88: 3613–3617.
Atassi, M. Z., Dolimbek, B. Z., and Manshouri, T. (1995). Mol. Immunol. 13: 927–932.
Atassi, M. Z., Dolimbek, B. Z., Hayakari, M., Middlebrook, J. L., Whitney, B., and Oshima, M. (1996). J. Prot. Chem. 15: 691–700.
Bandyopadhyay, S., Clark, A. W., Das Gupta, B., and Sathyamoorthy, V. (1987). J. Biol. Chem. 262: 2660–2663.
Beers, W. H., and Reich, E. (1969). J. Biol. Chem. 244: 4473–4479.
Binz, T., Kurazona, H., Popoff, M. R., Eklund, M. W., Sakaguchi, G., Kozaki, S., Krieglstein, K., Heuschen, A., Gill, D. M., and Niemann, H. (1990). Nucl. Acids Res. 18: 5556–5556.
Binz, T., Kurazono, H., Micaela, W., Frevert, J., Wernars, K., and Niemann, H. (1990). J. Biol. Chem. 265: 9153–9158.
Bixler, G. S., Jr., Bean, M., and Atassi, M. Z. (1986). Biochem. J. 240: 139–146.
Bixler, G. S., and Atassi, M. Z. (1984). J. Immunogen. 11: 339–353.
Brooks, V. B. (1956). J. Physiol. 134: 264–277.
Burgen, A. S. V., Dickens, F., and Zatman, L. J. (1949). J. Physiol. (London) 109: 10–24.
Byrne, M. P., and Smith, L. A. (2000). Biochimie 82: 955–966.
Campbell, K. D., Collins, M. D., and East, A. K. (1993a). J. Clin. Microbiol. 31: 2255–2262.
Also, B3: C. botulinum (strain nonproteolytic Eklund 2B) gene for neurotoxin type B. Accession # X70819. (ref. same as B2); B4: C. botulinum (strain proteolytic B) gene for neurotoxin type B. Accession # X70817. (ref. same as B2); B5: Clostridium botulinum neurotoxin type B (botB) gene, complete cds Accession # M81186.
Campbell, K., Collins, M. D., and East, A. K. (1993b). Biochim. Biophys. Acta 1216: 487–491.
Clayton, M. A., Clayton, J. M., Brown, D. R., and Middlebrook, J. L. (1995). Infect. Immun. 63: 2738–2742.
Das Gupta, B. R. and Sugiyama, H. (1972). Biochem. Biophys. Res. Commun. 48: 108–112.
Dertzbaugh, M. T., and West, M. W. (1996). Vaccine 14: 1538–1544.
Dickson, E. C., and Shevky, R. (1923b). Botulism studies on the manner in which the toxin of clostridium botulinum acts upon the body. II. The effect upon the autonomic nervous system. J. Exp. Med. 37: 711–731.
Dickson, E. C., and Shevky, R. (1923a). Botulism studies on the manner in which the toxin of clostridium botulinum acts upon the body. I. The effect on the voluntary nervous system. J. Exp. Med. 37: 327–346.
Dolimbek, B. Z., and Atassi, M. Z. (1994). α-Bungarotoxin peptides afford a synthetic vaccine against toxin poisoning. J. Prot. Chem. 13: 490–493.
Dolimbek, B. Z., and Atassi, M. Z. (1996). Mol. Immunol. 33: 681–689.
East, A. K., Richardson, P. T., Allaway, D., Collins, M. D., Roberts, T. A., and Thompson, D. E. (1992). FEMS Microbiol. Lett. 75: 225–230.
Eisel, U., Jarausch, W., Goretzki, K., Henschen, A., Engels, J., Weller, U., Hudel, M., Habermann, E., and Niemann, H. (1986). EMBO J. 5: 2495–2502.
Fu, F. N., Lomneth, R. B., Cai, S., and Singh, B. R. (1998). Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry 37: 5267–5278.
Gundersen, C. B. (1980). Prog. Neurobiol. 14: 99–119.
Hauser, D., Eklund, M. W., Kurazono, H., Binz, T., Niermann, H., Gill, D. M., Goquet, P., and Popoff, M. R. (1990). Nucl. Acids Res. 18: 4924–4924.
Hauser, D., Gibert, M., Marvaud, J. C., Eklund, M. W., and Popoff, M. R. (1995). Toxicon 33: 515–526.
Hutson, R. A., Collins, M. D., East, A. K., and Thompson, D. E. (1994). Curr. Microbiol. 28: 101–110.
Iwasaki, M., Ohishi, I., and Sakaguchi, G. (1980). Infect. Immun. 29: 390–394.
Kazim, A. L., and Atassi, M. Z. (1977). Biochem. J. 167: 275–278.
Kazim, A. L., and Atassi, M. Z. (1980). Biochem. J. 191: 261–264.
Kazim, A. L., and Atassi, M. Z. (1982). Biochem. J. 203: 201–208.
Kimura, K., Fujii, N., Tsuzuki, K., Murakami, T., Indoh, T., Yokosawa, N., Takeshi, K., Syuto, B., and Oguma, K. (1990). Biochem. Biophys. Res. Commun. 171: 1304–1311.
Kozaki, S., Miyazaki, S., and Sakaguchi, G. (1977). Infect. Immun. 18: 761–766.
Kozaki, S., Togashi, S., and Sakaguchi, G. (1981). Japan J. Med Sci. Biol. 34: 61–68.
Kozaki, S., Kamata, Y., Nagai, T., Ogasawara, J., and Sakaguchi, G. (1986). Infect. Immun. 52: 786–791.
Kozaki, S., Akira, M., Yoichi, K., Jun, O., and Genji, S. (1989). Infect. Immun. 57: 2634–2639.
Krieglstein, K. G., DasGupta, B. R., and Henschen, A. H. (1994). J. Prot. Chem. 13: 49–57.
Kubota, T., Watanabe, T., Yokosawa, N., Tsuzuki, K., Indoh, T., Moriishi, K., Sanda, K., Maki, Y., Inoue, K., and Fujii, N. (1997). Applied & Environmental Microbiol. 63: 1214–1218.
Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., and Stevens, R. C. (1998). Nat. Struct. Biol. 5: 898–902.
Llamana, C. (1959). Science 130: 763–772.
Middlebrook, J. L. (1989). Cell surface receptors for protein toxins, In Botulinum Neurotoxin and Tetanus Toxin (Simpson, L. L., Ed.). Academic Press, New York, pp. 95–119.
Middlebrook, J. L. (1995). Adv. Exp. Med. Biol. 383: 93–98.
Miyazaki, S., Iwasaki, M., and Sakaguchi, G. (1977). Infect. Immun. 17: 395–401.
Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M., and Kozaki, S. (1994). J. Biol. Chem. 269: 10498–10503.
Nowakowski, A., Wang, C., Powers, D. B., Amersdorfer, P., Smith, T. J., Montgomery, V. A., Sheridan, R., Bloke, R., Smith, A., and Marks, J. D. (2002). Proc. Natl. Acad. Sci. U. S. A. 99: 11346–11350.
Ohishi, I., and Sakaguchi, G. (1975). Appl. Microbiol. 29: 444–447.
Oshima, M., Middlebrook, J. L., and Atassi, M. Z. (1998). Immunol. Lett. 60: 7–12.
Oshima, M., Hayakari, M., Middlebrook, J. L., and Atassi, M. Z. (1997). Mol. Immunol. 34: 1031–1040.
Rosenberg, J. S., Middlebrook, J. L., and Atassi, M. Z. (1997). Immunol. Invest. 26: 491–504.
Sakaguchi, G., Ohishi, I., and Kozaki, S. (1988). Botulism-Structure and chemistry of botulinum in Handbook of Natural Toxins (Hardgree, M. C. and Tu, A. T., Eds.), Vol. 4, Marcel Dekker, New York, pp. 191–216.
Schiavo, G., Shone, C. C., Bennett, M. K., Scheller, R. H., and Montecucco, C. (1995). J. Biol. Chem. 270: 10566–10570.
Simpson, L. L. (1980). J. Pharmacol. Exp. Ther. 212: 16–21.
Simpson, L. L. (1981). Pharmacol. Rev. 33: 155–188.
Simpson, L. L. (1986). Ann. Rev. Pharmacol. Toxicol. 26: 427–453.
Simpson, L. L. (1989). Peripheral actions of the botulinum toxins, In Botulinum neurotoxin and Tetanus toxin (Simpson, L. L., Ed.), Academic Press, New York, pp. 153–178.
Simpson, L. L. (1990). J. Physiol., Paris 84: 143–151.
Spanoyannis, A., Foster, S. A., Peng, K., Merlino, G., and Aoki, R. (1998). Developmental Medicine and Child Neurology 40(Suppl 78): 33.
Sugui, S., and Sakaguchi, G. (1975). Infec. Immun. 12: 1262–1270.
Whelan, S. M., Elmore, M. J., Bodsworth, N. J., Atkinson, T., and Minton, N. P. (1992). Eur. J. Biochem. 204: 657–667.
Woodward, L., Arimitsu, A. H., Hirst, R., and Oguma, K. (2003). Infect. Immun. 71: 2941–2944.
Yang, K. H., and Sugiyama, H., (1975). Appl. Microbiol. 29: 598–603.
Yoshioka, N., and Atassi, M. Z. (1986). Biochem. J. 234: 441–447.
Rights and permissions
About this article
Cite this article
Atassi, M.Z., Dolimbek, B.Z. Mapping of the Antibody-Binding Regions on the HN-Domain (Residues 449–859) of Botulinum Neurotoxin A with Antitoxin Antibodies from Four Host Species. Full Profile of the Continuous Antigenic Regions of the H-Chain of Botulinum Neurotoxin A. J Protein Chem 23, 39–52 (2004). https://doi.org/10.1023/B:JOPC.0000016257.91979.06
Published:
Issue Date:
DOI: https://doi.org/10.1023/B:JOPC.0000016257.91979.06